Iomeron (Iomeprol)

Iomeprol contains iodine atoms that absorb X‑ray photons, increasing the radiodensity of blood and extracellular fluids. When injected, it creates a temporary contrast between vascular and tissue structures, allowing imaging systems to differentiate anatomical details more clearly.

The dose of Iomeron is determined by the prescribing physician based on the specific imaging study, patient weight, renal function, and clinical protocol. Healthcare professionals calculate the appropriate volume and concentration for each individual case.

Iomeron is classified as Pregnancy Category B, indicating that animal studies have not shown risk but there are limited human data. It should be used in pregnancy only if the diagnostic benefit outweighs potential risks. Breastfeeding mothers should consult their physician, as the drug may be excreted in small amounts in milk.

To order Iomeron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including cold‑chain handling if needed) and assists with import documentation.

Iomeron (Iomeprol) is a low‑osmolality, non‑ionic iodinated contrast medium, offering a favorable safety profile compared with high‑osmolality agents. It provides high image quality with reduced incidence of adverse reactions, making it comparable to other modern agents such as Iohexol or Iopamidol, while maintaining EU‑approved standards.

Iomeron should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use to maintain sterility and stability.

Iomeron is administered as a sterile solution for injection via the intravenous or intra‑arterial route. The injection is performed by qualified healthcare personnel, typically using a power injector or manual bolus, following the imaging protocol prescribed by the radiologist.

The most serious risks include severe allergic reactions (anaphylaxis), contrast‑induced nephropathy leading to acute kidney injury, and thyroid dysfunction such as hyperthyroidism. Patients with compromised renal function or known iodine allergy require careful assessment before use.

Iomeron should be avoided in patients with a documented hypersensitivity to iodinated contrast media, those with severe renal impairment (eGFR < 30 mL/min/1.73 m²) unless absolutely necessary, and in individuals with uncontrolled hyperthyroidism. Clinicians must evaluate each patient’s risk factors before administration.